Yoshimura Satoshi, Hashimoto Katsuhiko, Shono Yuji, Tamura Takahiro, Uchimido Ryo, Ando Koichi, Okamori Satoshi, Yoshida Takuo, Yoshitake Shigenori, Okada Yohei
Department of Preventive Services, School of Public Health, Kyoto University, Japan.
Department of Emergency Medicine, Rakuwakai Otowa Hospital, Japan.
Intern Med. 2025 Jul 1;64(13):1955-1964. doi: 10.2169/internalmedicine.4292-24. Epub 2024 Dec 5.
Objective Despite the controversy regarding its clinical utility, the arterial oxygen partial pressure (PaO) to the fraction of inspired oxygen (FIO) ratio has been used to define the severity of acute respiratory distress syndrome (ARDS). This systematic review and meta-analysis (SRMA) details summary estimates of the predictive performance of PaO/FIO ratio in predicting mortality in patients with ARDS. Methods To clarify the integrated diagnostic accuracy, we included studies in which the study population comprised patients with ARDS in any clinical setting, included adult patients (≥18 years old), and evaluated mortality. The MEDLINE and Cochrane Central Registry of Controlled Trials databases were searched for articles in English. We performed SRMA on the accuracy of the diagnostic prognostic tests using the Quality Assessment of Diagnostic Accuracy Studies-2 tool to evaluate the risk of bias. We obtained summary point estimates of sensitivity and specificity and calculated the area under the receiver operating characteristic (AUROC) curve of the summary receiver operating characteristic curve with 95% confidence intervals (CIs). Results Twenty-eight trials with 38,270 patients were included in the quality assessment. Most of the studies were conducted in intensive-care units. Overall, the risk of bias is high. For PaO/FIO of 100 and 200 the pooled sensitivity, specificity, and AUROC were 44.8% (95% CI, 38.1-51.7%), 70.6% (95% CI, 65.9-74.9%), 0.60 (0.58-0.64) and 83.9% (95% CI, 78.9-87.8%), 26.1% (95% CI, 20.8-32.1%), 0.64 (0.60-0.69), respectively. Conclusion The PaO/FIO ratio alone did not have impressive prediction accuracy for mortality in patients with ARDS and might not be able to be used solely as a clinical prognostic tool.
目的 尽管关于其临床效用存在争议,但动脉血氧分压(PaO)与吸入氧分数(FIO)的比值已被用于定义急性呼吸窘迫综合征(ARDS)的严重程度。本系统评价和荟萃分析(SRMA)详细阐述了PaO/FIO比值预测ARDS患者死亡率的预测性能的汇总估计值。方法 为明确综合诊断准确性,我们纳入了研究人群为任何临床环境下的ARDS患者、包括成年患者(≥18岁)并评估死亡率的研究。在MEDLINE和Cochrane对照试验中央注册库数据库中检索英文文章。我们使用诊断准确性研究质量评估-2工具对诊断性预后试验的准确性进行SRMA,以评估偏倚风险。我们获得了敏感性和特异性的汇总点估计值,并计算了汇总受试者工作特征曲线的受试者工作特征(AUROC)曲线下面积及95%置信区间(CI)。结果 质量评估纳入了28项试验,共38270例患者。大多数研究在重症监护病房进行。总体而言,偏倚风险较高。对于PaO/FIO为100和200时,合并敏感性、特异性和AUROC分别为44.8%(95%CI,38.1-51.7%)、70.6%(95%CI,65.9-74.9%)、0.60(0.58-0.64)和83.9%(95%CI,78.9-87.8%)、26.1%(95%CI,20.8-32.1%)、0.64(0.60-0.69)。结论 单独的PaO/FIO比值对ARDS患者死亡率的预测准确性并不令人印象深刻,可能无法单独用作临床预后工具。